Unveiling AOSD: Connecting the Dots in the Spectrum of Still's Disease

Host: Christopher T. Ritchlin, MD, MPH <br> Guest: Petros Efthimiou, MD, FACR <br> Guest: Olga Petryna, MD, FACR <br> <p>Is it time to connect the dots between systemic juvenile idiopathic arthritis (SJIA) and adult-onset Still’s disease (AOSD)? There is a growing recognition that SJIA and AOSD represent the same disease continuum with different ages of onset.¹ Both conditions are rare autoinflammatory disorders of unknown etiology.¹ In addition to Still’s disease rarity, patients present with varying symptoms and are diagnosed by exclusion of other diseases, which may result in a long time to proper care.^2,3 A delay in diagnosis and failure to control disease activity can lead to severe and life-threatening complications.⁴A multidisciplinary team effort and greater disease awareness are necessary to help expedite the therapeutic journey of patients with Still’s disease.⁵</p> <p>Listen in to a discussion panel moderated by Christopher T. Ritchlin, MD with Petros Efthimiou, MD and Olga Petryna, MD as they have a conversation on the concept of the continuum of Still’s disease, its burden, and the patient journey.</p> <p><span>This presentation is sponsored by Novartis Medical Affairs and all speakers have been compensated for their time.</span></p> <p><strong>References</strong></p> <ol> <li>Vastert SJ, Jamilloux Y, Quartier P, et al. Anakinra in children and adults with Still’s disease. <em>Rheumatology.</em> 2019;58(suppl 6):vi9-vi22. doi:10.1093/rheumatology/kez350</li> <li>Efthimiou P. Diagnosis and management of adult onset ...